# Safety and Efficacy of Angiotech Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access

> **NCT00448708** · NA · TERMINATED · sponsor: **Angiotech Pharmaceuticals** · enrollment: 222 (actual)

## Conditions studied

- Kidney Diseases
- ESRD

## Interventions

- **DEVICE:** Vascular Wrap Paclitaxel-Eluting Mesh
- **DEVICE:** Lifespan® ePTFE Vascular Graft
- **DEVICE:** Lifespan® ePTFE Vascular Graft

## Key facts

- **NCT ID:** NCT00448708
- **Lead sponsor:** Angiotech Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 222 (ACTUAL)
- **Why stopped:** Due to an imbalance in graft infections between groups.
- **Last updated:** 2011-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00448708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00448708, "Safety and Efficacy of Angiotech Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00448708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*